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Abstract
Lynch syndrome (hereditary nonpolypsis colorectal cancer or HNPCC) is a common cancer predisposition syndrome.
Predisposition to cancer in this syndrome results from increased accumulation of mutations due to defective mismatch
repair (MMR) caused by a mutation in one of the mismatch repair genes MLH1, MSH2, MSH6 or PMS2/scPMS1. To better
understand the function of Mlh1-Pms1 in MMR, we used Saccharomyces cerevisiae to identify six pms1 mutations (pms1-
G683E, pms1-C817R, pms1-C848S, pms1-H850R, pms1-H703A and pms1-E707A) that were weakly dominant in wild-type cells,
which surprisingly caused a strong MMR defect when present on low copy plasmids in an exo1D mutant. Molecular
modeling showed these mutations caused amino acid substitutions in the metal coordination pocket of the Pms1
endonuclease active site and biochemical studies showed that they inactivated the endonuclease activity. This model of
Mlh1-Pms1 suggested that the Mlh1-FERC motif contributes to the endonuclease active site. Consistent with this, the mlh1-
E767stp mutation caused both MMR and endonuclease defects similar to those caused by the dominant pms1 mutations
whereas mutations affecting the predicted metal coordinating residue Mlh1-C769 had no effect. These studies establish that
the Mlh1-Pms1 endonuclease is required for MMR in a previously uncharacterized Exo1-independent MMR pathway.
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Introduction
DNA mismatch repair (MMR) acts to repair the potentially
mutagenic misincorporation errors that occur during normal DNA
replication and the absence of MMR results in increased rates of
accumulating mutations. Consequently, defects in human MMR
genes cause the hereditary cancer susceptibility syndrome
HNPCC (hereditary nonpolypsis colorectal cancer, otherwise
known as Lynch syndrome) [1,2], and loss of MMR function also
appears to underlie the development of some sporadic cancers [3–
7]. MMR also repairs mispaired bases that occur in recombination
intermediates as well as prevents inappropriate recombination
between DNAs with imperfect homology where recombination
could result in genome rearrangements [8–10].
The mechanism of MMR has been extensively characterized in
both E. coli and different eukaryotic systems, with E. coli MMR
being the best characterized [11–14]. In E. coli MMR, mismatches
are recognized by the MutS homodimer [15,16]. Mispair bound
MutS then recruits the MutL homodimer [17]. This recruitment
leads to activation of the MutH endonuclease, which introduces
single strand breaks, called nicks, at unmethylated GATC sites in
the newly replicated and hemimethylated DNA strand [18]. Next,
a combination of the UvrD helicase and one of four single
stranded DNA specific exonucleases excise the nicked strand past
the mispair and the resulting singled-stranded gap is filled in by
DNA polymerase III, single strand DNA binding protein and
DNA ligase [14,19].
In eukaryotes mispairs are recognized by either Msh2-Msh6 or
Msh2-Msh3, two partially redundant heterodimers of MutS family
member proteins [12,20,21]. Mispair bound Msh2-Msh6 and
Msh2-Msh3 recruit the MutL related complex, called Mlh1-Pms1
in S. cerevisiae and Mlh1-Pms2 in human and mouse [11,12,22–24].
The Pms1/Pms2 subunit of the Mlh1-Pms1/Pms2 complex is
known to contain an endonuclease active site, suggesting that
Mlh1-Pms1/Pms2 may be analogous to a combination of both E.
coli MutL and MutH [25,26]. Exo1, a DNA exonuclease from the
Rad2/XPG family, has been implicated in the excision step of
eukaryotic MMR; however, mutations in S. cerevisiae and mouse
EXO1 only result in partial MMR defects, suggesting the existence
of additional excision mechanisms [27–29]. Genetic and biochem-
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ical studies have also implicated DNA polymerase d, RPA, RFC
and PCNA in MMR [12,30–37] and have suggested that several
of these proteins including PCNA and RFC may function both
prior to excision and in the resynthesis steps of MMR
[25,26,33,38].
MMR is spatially and temporally coupled to replication in vivo
[38,39], providing a mechanism to bring MMR proteins into the
proximity of newly formed mispairs. DNA replication generates
nicks in the nascent DNA strands that may be involved in MMR
[30,34,40,41], consistent with the observation that discontinuous
lagging strand MMR is more dependent on excision catalyzed by
Exo1 than leading strand MMR [38,42]. Furthermore, preexisting
nicks in DNA target the Mlh1-Pms1/Pms2 endonuclease to the
nicked strand in vitro [43]. However, these results raise two
unresolved questions: Why is it necessary to target additional nicks
to an already nicked DNA strand, and if preexisting nicks can
support MMR in vitro then why is Mlh1-Pms1 absolutely required
for MMR in vivo? Part of the answer to the apparent contradictions
implied by these experimental results could be the presence of
multiple MMR pathways in which the same MMR proteins have
differing roles. Consistent with this, biochemical studies have
identified two types of excision mechanisms that may function in
MMR, excision by Exo1 [44] and strand displacement synthesis
toward the mispair by DNA polymerase d potentially coupled with
flap cleavage [45]. Both mechanisms could act at either a pre-
existing 59 nick or a 59 nick introduced by the Mlh1-Pms1/Pms2
endonuclease. Genetic studies have also identified Exo1-depen-
dent and -independent MMR pathways [27]. The Exo1-indepen-
dent pathway requires the PCNA-Msh2-Msh6 interaction and the
Pol32 subunit of DNA polymerase d and is inactivated by
separation-of-function mutations affecting Mlh1, Pms1, Msh2,
Msh3, and PCNA that do not affect Exo1-dependent MMR
[27,38]. How these mutations specifically affect in the Exo1-
independent MMR pathway and how this pathway excises the
nascent DNA strand is unclear.
To better understand the role of both Mlh1-Pms1 and Exo1 in
MMR, we performed a genetic screen for dominant mutations in
the PMS1 gene. We identified pms1 null missense mutations that
caused weakly dominant MMR defects when present in a wild-
type S. cerevisiae strain on a single-copy plasmid. Interestingly, these
mutations caused much stronger MMR defects when present on a
single-copy plasmid in an exo1D mutant. Analysis of these
mutations using the structure of the C-terminal domains of
Mlh1-Pms1 [46] predicted that three amino acids altered by these
mutations were metal ligands in the Mlh1-Pms1 nuclease active
site and the fourth was a residue adjacent to the metal binding site.
Biochemical analysis of mutant proteins confirmed that both pms1
and mlh1 mutations affecting the predicted active site eliminated or
significantly reduced the RFC-PCNA dependent nuclease activity
of Mlh1-Pms1 and in vivo imaging showed that the same mutations
resulted in accumulation of Mlh1-Pms1-4GFP foci consistent with
failure to execute a downstream step in MMR. These results both
define the nuclease active site of the Mlh1-Pms1 endonuclease and
thoroughly characterize the role of this endonuclease activity in a
previously uncharacterized Exo1-independent MMR sub-path-
way.
Results
Identification of dominant pms1 mutations
To gain insight into the role of PMS1 in mismatch repair, we
sought to generate novel pms1 mutations that cause a dominant
MMR defect. First we mutagenized the PMS1 gene by PCR
amplification and gap-repaired the resulting DNA fragments into
the low copy number ARS CEN pRS316 plasmid by co-
transformation into a S. cerevisiae strain with a wild-type PMS1
gene. A total of 38,000 transformants were screened for increased
reversion of the lys2-10A frameshift mutation. This screen
identified 211 transformants potentially containing dominant
pms1 mutations. Rescreening these 211 transformants for in-
creased reversion of the hom3-10 frameshift mutation identified 8
transformants with mutator phenotypes. The pms1 mutation-
bearing plasmids were isolated from these 8 transformants, and the
PMS1 gene from each plasmid was sequenced. Site directed
mutagenesis and sub-cloning were used to construct PMS1
plasmids containing single point mutations. These mutant
plasmids were retested in the three mutator assays confirming
four dominant pms1 mutations resulting from amino acid
substitutions in the C-terminal domain of Pms1: G683E,
C817R, C848S, and H850R.
Three dominant mutations eliminate metal binding
ligands in the Pms1 endonuclease domain
The four amino acid substitutions resulting from the dominant
mutations altered highly conserved amino acids (Figure 1A). Initial
analysis of these amino acid substitutions using a homology model
based on the C-terminal domains of endonuclease-proficient and
zinc-binding Neisseria gonorrhoeae and Bacillus subtilis MutL homologs
[47,48] indicated that they affect the active site of the Pms1
endonuclease. Mapping of the amino acid substitutions onto the
newly available structure of the C-terminal domains of Mlh1-Pms1
(Figure 1B,C) confirmed that the C817R, C848S, and H850R
amino acid substitutions each eliminated one of the 5 metal ligands
in the Pms1 endonuclease active site; all 5 ligands are conserved in
eukaryotic ScPms1/HsPMS2 proteins and in the N. gonorrhoeae and
B. subtilis MutL homologs [47,48]. The fourth amino acid
substitution, G683E, mapped to a conserved position adjacent to
sites of metal coordination and could sterically disrupt the site or
locally perturb the structure. We also constructed mutations
resulting in the amino acid substitutions H703A and E707A to
eliminate the remaining two predicted metal ligands not identified
in our screen.
Author Summary
Lynch syndrome (hereditary nonpolypsis colorectal cancer
or HNPCC) is a common cancer predisposition syndrome.
Predisposition to cancer in this syndrome results from
increased accumulation of mutations due to defective
mismatch repair (MMR) caused by a mutation in one of the
mismatch repair genes MLH1, MSH2, MSH6 or PMS2/
scPMS1. In addition to these genes, various DNA replica-
tion factors and the excision factor EXO1 function in the
repair of damaged DNA by the MMR pathway. Although
EXO1 is considered to be the major repair nuclease
functioning in mismatch repair, the relatively low mutation
rates caused by an exo1 deletion suggest otherwise. Here
we used genetics, microscopy and protein biochemistry to
analyze the model organism Saccharomyces cerevisiae to
further characterize a poorly understood mismatch repair
pathway that functions in the absence of EXO1 that is
highly dependent on the Mlh1-Pms1 complex. Surprising-
ly, we found that the highly conserved metal binding site
that is critical for the endonuclease activity of the Mlh1-
Pms1 heterodimer is required for MMR in the absence of
Exo1 to a much greater extent than in the presence of
Exo1. Thus, this work establishes that there are at least two
different polynucleotide excision pathways that function in
MMR.
Dominant PMS1 Mutants in EXO1-Independent Repair
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Figure 1. Conserved amino acid residues comprise the Mlh1-Pms1 endonuclease active site. A. Alignments of fungal Pms1 and animal
Pms2 sequences from Sce (Saccharomyces cerevisiae NP_0141317.2), Ncr (Neurospora crassa XP_962690.2), Spo (Schizosaccharomyces pombe
NP_594417.1), Mbr (Monosigna brevicollis XP_001747286.1), Dme (Drosophila melanogaster NP_477023.1), Dpu (Daphnia pulex EFX87911.1), Cel
(Caenorhabitis elegans NP_505933.1), Spu (Strongylocentrotus purpuratus XP_786592.2), Hsa (Homo sapiens NP_000526.1) using Clustal Omega [72].
Asterisks indicate stop codons. Highlighted columns indicate perfectly conserved residues in the nine aligned species. Yellow triangles indicate the
positions of mutations isolated in the screen. Orange triangles indicate the positions of engineered mutations generated in this study. B. Homology
model of S. cerevisiae Mlh1-Pms1 with Mlh1 in green and Pms1 in red. The unstructured linker between the N- and C-terminal domains depicted as a
dashed line. The position of the C-terminal active site is boxed. C. Modeled Pms1 endonuclease active site is displayed with the positions of amino
acid substitutions isolated in the genetic screen shown with yellow ball-and-stick side chains and the position of the other metal ligands in orange.
Position of the Mlh1 C-terminal FERC motif displayed as green ball-and-stick side chains. D. Alignments of fungal and animal Mlh1 sequences as in
panel A from Sce (Saccharomyces cerevisiae NP_013890.1), Ncr (Neurospora crassa XP_962522.1), Spo (Schizosaccharomyces pombe NP_596199.1), Mbr
(Monosigna brevicollis, reannotated starting from XP_001745742.1), Dme (Drosophila melanogaster, NP_477022.1), Dpu (Daphnia pulex, EFX86130.1),
Cel (Caenorhabitis elegans NP_499796.2), Spu (Strongylocentrotus purpuratus XP_793318.2) and Hsa (Homo sapiens NP_000240.1).
doi:10.1371/journal.pgen.1003869.g001
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Fluctuation analysis was performed to evaluate the mutator
effects of the dominant pms1 mutants. Mutation rates were
measured using the CanR forward mutation assay and the hom3-10
and lys2-10A frameshift reversion assays [21,27] when the pms1
dominant mutations were present on low copy plasmids in a strain
with a wild-type PMS1 gene (Table 1). None of the mutant
plasmids caused more than a 2-fold increased mutation rate in the
CanR assay, which has a relatively high background mutation rate
in wild-type cells and a low sensitivity for detecting MMR defects.
In contrast, the mutations on the low copy plasmid caused
between a 2- and 102-fold increase in mutation rate in the hom3-10
and lys2-10A assays compared to introduction of a wild-type copy
of PMS1 on a low copy plasmid. Introduction of these mutations
onto a high copy 2-micron plasmid resulted in much higher rates
(Table S1), but still did not cause mutation rates that were as high
as caused by deletion of PMS1 (Compare Table S1 to Table S2).
The pms1 mutant plasmids were also unable complement a pms1D
strain above that seen for the vector control (Table S2). Taken
together, the fluctuation analysis indicated that the dominant pms1
mutations were null PMS1 alleles that caused a copy-number
dependent dominant mutator phenotype. This dominant mutator
phenotype was stronger for mutations causing amino acid
substitutions of metal ligands as compared to the pms1-G683E
mutation.
Disruption of metal coordination inhibits endonuclease
function
Previous studies have shown that S. cerevisiae Mlh1-Pms1 has a
metal-dependent endonuclease activity that can be stimulated by
RFC and PCNA [26]. To determine if the dominant pms1
mutations affecting metal ligating amino acids disrupt the
endonuclease function of Mlh1-Pms1, we expressed and purified
the S. cerevisiae wild-type Mlh1-Pms1 complex and the mutant
Mlh1-Pms1-G683E, Mlh1-Pms1-C817R, Mlh1-Pms1-C848S, and
Mlh1-Pms1-H850R complexes and assayed the ability of these
complexes to nick supercoiled pRS425 plasmid DNA with or
without accessory factors RFC-D1N and PCNA (Figure 2A). Wild-
type Mlh1-Pms1 alone showed little endonuclease activity.
However, addition of PCNA and RFC-D1N to reactions
containing wild-type Mlh1-Pms1 resulted in a 20-fold increase in
endonuclease activity resulting in cleavage of nearly half of the
original substrate DNA. The newly identified Mlh1-Pms1 mutant
proteins and the previously studied Mlh1-Pms1-E707K mutant
protein did not exhibit any PCNA and RFC-D1N stimulated
endonuclease activity, with the exception of the Mlh1-Pms1-
H850R mutant protein (Figure 2A). An explanation of the ability
of the Mlh1-Pms1-H850R mutant protein to nick supercoiled
DNA is provided in the ‘‘Discussion’’. These results support the
idea that loss of metal coordination by Pms1 inhibits the
endonuclease activity of Mlh1-Pms1.
PMS1 metal coordination mutations cause a synthetic
mutator phenotype when combined with an exo1D
mutation
Exo1 is a 59-39 nuclease that functions in MMR in vitro by
resecting DNA from a preexisting nick to a point past the mispair
[28,44,49]. Loss of Exo1 function in vivo by deletion of EXO1 or
missense mutations inactivating the Exo1 active site only results in
a weak mutator phenotype and hence only partial loss of MMR
(Table 1) [27–29,50]. To determine the consequences of
eliminating the two known nucleases involved in S. cerevisiae
MMR, we tested the effect of introducing plasmids containing the
dominant pms1 mutations into an exo1D mutant strain containing a
wild-type PMS1 gene. Relative to the effects in a wild-type strain,
Table 1. Mutation rates of pms1 metal coordination mutants on a low-copy plasmid in wild-type and exo1D strains.
Mutation rate [95%CI] (fold increase relative to PMS1)*
Plasmid
Genotype
Yeast
Genotype Thr+ Lys+ CanR
PMS1 wild-type 7.31 [3.10–9.86]61029 (1) 2.12 [1.08–2.89]61028 (1) 1.58 [1.25–3.13]61027 (1)
EV wild-type 7.58 [3.22–9.14]61029 (1) 2.12 [1.33–3.47]61028 (1) 2.34 [1.29–2.89]61027 (1.5)
pms1H703A wild-type 6.59 [3.86–13.2]61028 (9) 7.02 [4.12–9.85]61027 (33) 2.66 [1.77–3.81]61027 (2)
pms1E707A wild-type 3.52 [2.59–6.75]61028 (5) 4.18 [2.23–7.30]61027 (20) 2.13 [1.40–4.55]61027 (1)
pms1G683E wild-type 1.64 [0.82–7.14]61028 (2) 3.74 [2.47–4.64]61028 (2) 1.33 [0.55–1.49]61027 (1)
pms1C817R wild-type 4.67 [3.58–11.4]61028 (6) 1.51 [0.84–5.28]61027 (7) 3.50 [1.92–4.14]61027 (2)
pms1C848S wild-type 3.24 [1.86–5.98]61027 (44) 2.17 [0.64–4.52]61026 (102) 4.52 [2.36–10.2]61027 (3)
pms1H850R wild-type 3.13 [1.93–5.28]61028 (4) 1.99 [0.65–4.29]61027 (9) 2.48 [1.30–3.25]61027 (2)
PMS1 exo1D 2.13 [1.65–2.95]61028 (1) 7.62 [4.72–10.1]61028 (1) 9.19 [6.36–11.0]61027 (1)
EV exo1D 2.45 [1.02–4.83]61028 (1) 1.62 [1.0–2.44]61027 (2) 2.78 [1.12–4.64]61026 (3)
pms1H703A exo1D 1.47 [0.70–3.83]61026 (69) 1.40 [0.69–2.03]61025 (184) 1.79 [1.38–4.05]61026 (2)
pms1E707A exo1D 1.22 [0.71–2.02]61026 (57) 9.39 [6.82–15.5]61026 (123) 1.74 [1.27–2.32]61026 (2)
pms1G683E exo1D 3.36 [1.45–8.58]61027 (16) 2.75 [1.85–5.96]61026 (36) 1.66 [1.08–2.04]61026 (2)
pms1C817R exo1D 2.47 [1.03–3.01]61026 (116) 7.31 [5.06–11.2]61026 (96) 2.46 [1.67–3.17]61026 (3)
pms1C848S exo1D 3.57 [0.63–10.8]61026 (168) 1.60 [0.74–6.05]61025 (210) 2.83 [2.15–5.18]61026 (3)
pms1H850R exo1D 1.94 [1.06–3.21]61026 (91) 7.09 [3.35–13.6]61026 (93) 1.68 [1.27–2.86]61026 (2)
*Median rates of hom3-10 (Thr+) and lys2-10A (Lys+) reversion and inactivation of CAN1 (CanR) with 95% confidence interval (CI) in square brackets and fold increase
relative to complementation with pRS316-PMS1 in parentheses. For comparison, mutation rates for the pms1D strain complemented with empty vector (EV) are
[Thr+= 4.5161025, Lys+=2.7761024, Canr = 9.6161026].
doi:10.1371/journal.pgen.1003869.t001
Dominant PMS1 Mutants in EXO1-Independent Repair
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introduction of the dominant pms1 mutations on a low-copy
plasmid into the exo1D mutant strain increased the mutation rate
to a much greater extent (Table 1). The pms1-G683E mutation
again caused the weakest mutator phenotype, whereas the other
five pms1 mutations that affect the metal ligands caused relatively
high mutation rates ranging from a 57- to a 210-fold increased
mutation rate depending on the mutation and the assay. These
results show that the dominant pms1 mutations cause a greater
MMR defect in an exo1D mutant strain than in a wild-type strain,
suggesting that Exo1 and the Mlh1-Pms1 nuclease have a
redundant function in MMR.
Role of the conserved Mlh1 C-terminus in endonuclease
activity and MMR
The four C-terminal residues of Mlh1 are almost completely
conserved as the amino acids FERC in fungal and animal species
(Figure 1D). Furthermore, Mlh1 has no C-terminal extension
beyond the FERC residues in almost all sequenced eukaryotic
organisms except nematodes (FERCG[T/S]) whereas the
ScPms1/HsPMS2 family of proteins have variable length C-
terminal extensions (Figure 1D). Consistent with a special role for
the C-terminus of Mlh1, C-terminal fusions to the S. cerevisiaeMlh1
are non-functional for MMR in vivo, whereas C-terminal fusions to
S. cerevisiae Pms1 do not affect function [38]. A structure of this
highly conserved Mlh1 C-terminus (Figure 1B,C) revealed that this
region might be appropriately positioned to play a role at the
endonuclease active site of Pms1, with the C-terminal Mlh1
cysteine potentially acting as a metal ligand. We therefore
generated the mlh1-E767stp, mlh1-C769stp, mlh1-C769A and mlh1-
C769S mutations to probe the role of these highly conserved
residues in endonuclease activity in vitro and MMR in vivo.
Unlike the pms1 mutations affecting metal ligands, none of the
mutations affecting the C of the conserved FERC motif of Mlh1
that is predicted to be a metal ligand including the mlh1-C769A,
mlh1-C769S, and mlh1-C769stp mutations caused a dominant
mutator phenotype when present on an ARS CEN plasmid in a
wild-type strain or an exo1D strain (Table 2). The mlh1-C769A,
mlh1-C769S, and mlh1-C769stp mutants fully complimented the
MMR defect of an mlh1D strain (Table S2) consistent with
previously published results for the mlh1-C769A mutation but not
the mlh1-C769S mutation [51] or the mlh1-C769stp mutation [46].
In this regard, it should be noted that our studies used a broader
series of mutator assays, including more sensitive assays, than
previous studies of mutations affecting Mlh1-C767. In contrast,
the mlh1-E767stp mutant plasmid failed to complement the MMR
defect of an mlh1D strain and resulted in a null phenotype (Table
S2). Furthermore, the mlh1-E767stp mutation on an ARS CEN
plasmid caused a weak dominant mutator phenotype when
present in a wild-type strain and a stronger dominant mutator
phenotype when present in an exo1D strain (Table 2), although
not to the extent as that caused by the PMS1 metal ligand
mutations.
We also tested the effect of the mlh1-C769stp and mlh1-E767stp
mutations in the endonuclease assay (Figure 2B). The mutant
Mlh1-Pms1 protein lacking only the Mlh1 C-terminal cysteine
that did not cause an MMR defect in vivo nicked supercoiled
DNA to the same extent as the wild-type Mlh1-Pms1 protein. In
contrast, the mutant Mlh1-Pms1 protein resulting from the mlh1-
E767stp mutation was significantly defective for nicking super-
coiled plasmid DNA, which parallels the effect of this mutation
on MMR in vivo. These results support the idea that the C-
terminus of Mlh1 functions in the endonuclease active site
although if the terminal cysteine coordinates bound metal then
this role is not required for MMR or endonuclease activity
(Figure 1C).
Mlh1-Pms1 metal coordination mutants do not
preferentially affect MMR on the leading or lagging DNA
strands
Mutations affecting the active sites of leading and lagging
strand DNA polymerases Pol e, pol2-M644G, and Pol d, pol3-
L612M, have been identified that preferentially introduce
misincorporation errors in their respective strand during DNA
replication [52,53]. In a wild-type background, these lesions are
then efficiently corrected by MMR. This strand-biased mis-
incorporation can be used to determine strand preferences for
MMR [52,54,55]. Here we probed mutants containing these
polymerase active site mutations with ARS CEN plasmids
encoding endonuclease defective pms1 and mlh1 mutations to
investigate whether the Mlh1-Pms1 endonuclease preferentially
functions in leading or lagging strand MMR. We found that ARS
CEN PMS1 plasmids containing the pms1-C817R, pms1-C848S or
pms1-H850R mutations caused a statistically similar synergistic
increase in mutation rate when present in strains containing
mutations affecting either DNA polymerase (Table 3). Of nine
pairwise comparisons between pol2-M644G and pol3-L612M
mutants containing the same pms1 mutation on a low copy
plasmid using three different mutation rate assays, seven were
not different (p-value.0.05, Mann-Whitney test). For the two
Figure 2. Metal coordination mutations eliminate the ability of
Mlh1-Pms1 to nick closed circular DNA. Endonuclease reactions to
nick closed circular DNA were performed with Mlh1-Pms1 alone or with
Mlh1-Pms1, PCNA and RFC-D1N. A. Percentage of wild-type cleaved
product formed by wild-type Mlh1-Pms1 and mutant Mlh1-Pms1
complexes containing the indicated Pms1 amino acid changes. B.
Percentage of wild-type cleaved product formed by wild-type Mlh1-
Pms1 and mutant Mlh1-Pms1 complexes containing the indicated Mlh1
amino acid changes. 100% cleavage of the 100 ng of pRS425 in the
assay is 2.2 fmoles of cleavage events.
doi:10.1371/journal.pgen.1003869.g002
Dominant PMS1 Mutants in EXO1-Independent Repair
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comparisons that showed a difference, one showed a modestly
higher rate in the pol2-M644G strain while the other showed a
modestly higher rate in the pol3-L612M strain (p-value,0.05,
Mann-Whitney test). This degree of similarity between the pol2-
M644G and pol3-L612M mutants in these comparisons is in
marked contrast to the effect of an exo1D mutation that caused a
9-fold higher increase in mutation rate in a pol3-L612M mutant
compared to a pol2-M644G mutant [38]. Overall, these results
suggest that Mlh1-Pms1 functions similarly on both the leading
and lagging strands during MMR.
Mutations that affect Mlh1-Pms1 endonuclease function
exhibit increased levels of Pms1 foci
We have previously demonstrated that Mlh1-Pms1 foci are an
intermediate in MMR and that blocking MMR downstream of
Mlh1-Pms1 recruitment results in increased levels of Mlh1-Pms1
Table 2. Mutations rates of MLH1-FERC motif mutations on a low-copy plasmid in wild-type and exo1D strains.
Mutation rate [95%CI] (fold increase relative to MLH1)*
Plasmid
Genotype
Yeast
Genotype Thr+ Lys+ CanR
MLH1 wild-type ,1.35 [0.93–2.97]61028 (1.0) 3.47 [3.06–7.32]61028 (1.0) 2.36 [1.59–3.53]61027 (1.0)
EV wild-type 7.58 [3.22–9.14]61029 (0.6) 2.12 [1.33–3.47]61028 (0.6) 2.34 [1.29–2.89]61027 (1.0)
mlh1C769A wild-type 7.58 [5.53–14.2]61029 (0.6) 3.46 [2.14–5.21]61028 (1.0) 2.41 [1.51–2.91]61027 (1.0)
mlh1C769S wild-type 9.43 [5.88–16.5]61029 (0.7) 2.64 [1.53–3.71]61028 (0.8) 2.98 [1.68–4.21]61027 (1.3)
mlh1C769stp wild-type 1.17 [0.42–1.93]61028 (0.9) 2.20 [1.50–4.49]61028 (0.6) 2.53 [1.43–3.81]61027 (1.1)
mlh1E767stp wild-type 1.32 [0.88–2.05]61028 (1.0) 1.38 [0.63–1.83]61027 (4.0) 2.59 [1.50–3.65]610
27 (1.1)
MLH1 exo1D 3.13 [1.68–4.96]61028 (1.0) 2.45 [1.59–3.63]61027 (1.0) 1.20 [0.90–1.78]61026 (1.0)
EV exo1D 2.45 [1.02–4.83]61028 (0.8) 1.62 [1.0–2.44]61027 (1.5) 2.78 [1.12–4.64]61026 (2.3)
mlh1C769A exo1D 2.75 [1.47–7.58]61028 (0.9) 1.83 [1.40–2.65]61027 (0.7) 1.28 [0.96–1.56]61026 (1.2)
mlh1C769S exo1D 3.53 [0.90–7.58]61028 (1.1) 1.28 [0.84–2.69]61027 (0.5) 1.03 [0.82–1.53]61026 (0.9)
mlh1C769stp exo1D 4.24 [2.48–7.44]61028 (1.4) 1.32 [0.95–1.91]61027 (0.5) 1.08 [0.88–1.20]61026 (0.9)
mlh1E767stp exo1D 1.75 [0.81–5.26]61027 (5.6) 1.66 [1.01–2.30]61026 (6.8) 1.55 [0.93–2.23]61026 (1.3)
*Median rates of hom3-10 (Thr+) and lys2-10A (Lys+) reversion and inactivation of CAN1 (CanR) with 95% confidence interval (CI) in square brackets and fold increase
relative complementation with pRS316-MLH1 in parentheses. For comparison, mutation rates for the mlh1D strain complemented with empty vector (EV) are
[Thr+= 8.8861025, Lys+=2.2361024, Canr = 9.8561026].
doi:10.1371/journal.pgen.1003869.t002
Table 3. Mutations rates of pms1 metal coordination mutants on a low-copy plasmid in polymerase mutant strains pol2M644G
and pol3L612M.
Mutation rate [95%CI] (fold increase relative to PMS1)*
Plasmid
Genotype
Yeast
Genotype Thr+ Lys+ CanR
PMS1 pol2M644G 6.99 [3.43–10.8]61028 (1.0) 1.69 [0.73–2.25]61027 (1.0) 9.84 [4.99–32.4]61026 (1.0)
EV pol2M644G 1.03 [0.52–5.62]61027 (1.4) 3.49 [2.15–5.21]61027 (2.1) 1.93 [0.52–6.15]61025 (2.0)
pms1C817R pol2M644G 2.45 [0.73–11.9]61027 (3.5){ 1.44 [0.56–2.28]61026 (8.5)` 4.23 [1.66–12.0]61026 (0.43){
pms1C848S pol2M644G 1.92 [0.79–9.54]61026 (27){ 1.70 [0.06–3.6]61025 (100){ 5.18 [1.62–96.6]61026 (0.53){
pms1H850R pol2M644G 1.08 [3.19–24.4]61027 (1.5)` 2.19 [0.71–6.91]61027 (1.3){ 2.14 [1.04–6.77]610
26 (0.22){
PMS1 pol3L612M 5.79 [3.96–22.0]61028 (1.0) 1.10 [0.59–1.87]61027 (1.0) 3.78 [1.96–8.20]61026 (1.0)
EV pol3L612M 7.42 [5.29–10.6]61028 (1.2) 1.04 [0.72–2.14]61027 (0.9) 3.66 [2.20–4.67]61026 (1.0)
pms1C817R pol3L612M 3.38 [1.47–8.49]61027 (5.8){ 3.14 [2.15–6.62]61027 (2.9)` 2.71 [1.22–13.6]61026 (0.7){
pms1C848S pol3L612M 1.43 [0.35–8.19]61026 (25){ 3.14 [0.11–10.7]61026 (29){ 9.09 [0.84–32.9]61026 (2.4){
pms1H850R pol3L612M 2.76 [1.06–7.63]61027 (4.8)` 2.29 [1.39–6.09]61027 (2.1){ 1.96 [1.51–3.48]61026 (0.5){
*Median rates of hom3-10 (Thr+) and lys2-10A (Lys+) reversion and inactivation of CAN1 (CanR) with 95% confidence interval (CI) in square brackets and fold increase
relative to complementation with pRS316-PMS1 in parentheses.
{p-value.0.05 for a difference in mutation rate of the pol2M644G mutant compared to the pol3L612M mutant when both mutants contained the same indicated pms1
mutant plasmid (Mann-Whitney test).
`p-value,0.05 for a difference in mutation rate of the pol2M644G mutant compared to the pol3L612M mutant when both mutants contained the same indicated pms1
mutant plasmid (Mann-Whitney test).
doi:10.1371/journal.pgen.1003869.t003
Dominant PMS1 Mutants in EXO1-Independent Repair
PLOS Genetics | www.plosgenetics.org 6 October 2013 | Volume 9 | Issue 10 | e1003869
foci [38]. To test the effect of the Mlh1-Pms1 active site mutations
on the levels of Pms1 foci, different mlh1 and pms1 mutations were
introduced into the relevant endogenous locus in a strain in which
the single wild-type copy of PMS1 was functionally tagged with
four tandem copies of GFP. Normally, Mlh1-Pms1-4GFP foci are
present in approximately 10% of logarithmically growing wild-
type cells whereas all of the mutations that affected endonuclease
function in vitro that were tested caused increased Mlh1-Pms1-
4GFP foci formation (Figure 3). These included the metal
coordination pms1 mutations pms1-E707K, which was previously
tested [38], as well as pms1-C817R, pms1-C848S and pms1-H850R,
the pms1-G683E mutation and the mlh1-E767stp endonuclease
active site mutation, which increased the proportion of cells
containing Mlh1-Pms1-4GFP foci to between 64 and 96%. In
contrast, the endonuclease and MMR proficient mlh1-C769stp
mutation did not alter the levels of Mlh1-Pms1-4GFP foci
compared to wild-type strain. These results are consistent with
the idea that mispairs are recognized normally in these Mlh1-
Pms1 endonuclease active site mutants and that there is proper
loading of the mutant Mlh1-Pms1 on DNA but instead there is a
mispair processing defect resulting in decreased turnover of the
mutant Mlh1-Pms1 from the DNA [38].
Discussion
In this study, we used the highly sensitive lys2-10A frameshift
mutation reversion assay to screen mutagenized low copy PMS1
plasmids for pms1 mutations that caused a dominant mutator
phenotype in the presence of a single-copy of the wild-type PMS1
gene. We identified four null mutations that caused a weak
dominant phenotype under these conditions. These mutations all
caused amino acid substitutions in or near the region predicted to
contain the Pms1 endonuclease active site and three of the amino
acid substitutions including Pms1-C817R, Pms1-C848S, and
Pms1-H850R affected predicted metal binding motifs while
Pms1-G683 was in close proximity to the metal coordination site.
The weak effect of these mutations explains why a prior study of a
predicted Pms1 active site mutation did not observe a dominant
effect [56]. A model of the endonuclease active site predicted Pms1
amino acids H703 and E707 as well as Mlh1-C769 to also be a
part of the Mlh1-Pms1 active site [46]. Consistent with this model,
the pms1-H703A and pms1-H707A mutations were found to cause
the same phenotypes as the other PMS1metal ligand mutations. In
contrast, no mutation affecting Mlh1-C769 caused either a
dominant mutator phenotype or affected Mlh1 function whereas
the mlh1-E767stp mutation caused phenotypes that were similar to
those caused by the PMS1metal ligand mutations. Remarkably, all
of the pms1 mutations caused a stronger dominant mutator
phenotype when present in an exo1D strain on a low copy plasmid.
The mlh1-E767stp also caused an increased dominant mutator
affect in the exo1D strain, although not to the extent seen with the
pms1 mutations. The phenotype of these mutants is similar to
previously described separation-of-function mutations in MSH2,
MSH3,MSH6,MLH1, PMS1, POL30 and POL32 that cause strong
defects in Exo1-independent MMR but little if any defect in MMR
when Exo1 is functional [27].
The asymmetry of the endonuclease active site is consistent with
proposed roles of Mlh1-Pms1 in nicking double-stranded DNA
during MMR; however, this asymmetry is not present in
homodimeric bacterial MutL homologs with endonuclease func-
tion [47,48]. The similarity of the eukaryotic Mlh1-Pms1 and
bacterial MutL homologs suggests that MutL-DNA complexes
may be functionally asymmetric so that only one active site is
positioned to cleave DNA, analogous to the functional asymmetry
during mispair recognition by bacterial MutS homodimers
[15,16]. The asymmetry of the eukaryotic MutL complexes,
however, allows specialization of each subunit. The highly
conserved C-terminus of Mlh1 is positioned in the Mlh1-Pms1
structure in a way that suggests that the Mlh1-ScPms1/HsPMS2
and Mlh1-Mlh3 complexes have a composite endonuclease active
site. Potential roles for residues in the Mlh1 C-terminus include
coordinating DNA phosphates, promoting nucleophilic attack by a
water molecule or stabilization of the Pms1 active site. Consistent
with this, the mlh1-E767stp mutant plasmid did not complement
the mutator phenotype caused by a deletion of MLH1, and the
mlh1-E767stp mutation resulted in the accumulation of Mlh1-
Pms1-4GFP foci and reduced endonuclease activity similar to
mutations in PMS1 affecting the endonuclease active site. It was
surprising that mutation or deletion of the highly conserved C-
terminal cysteine did not cause a MMR defect in vivo or reduce
endonuclease activity in vitro given the possibility that this residue
might coordinate with metals in the endonuclease active site. It is
possible that conservation of the C-terminal cysteine may reflect
other roles for Mlh1, potentially including crossover resolution
during meiosis [57–59].
Analysis of the genetically identified and structure-based
mutations in the MLH1 and PMS1 genes revealed that disruption
of the metal binding sites leads to disruption of the Mlh1-Pms1
endonuclease activity and arrest of MMR repair at a step following
recruitment of Mlh1-Pms1 into microscopically-observable foci. In
a Mn2+-, RFC-, and PCNA-dependent endonuclease assay, amino
acid substitutions affecting all of the metal ligands caused defects in
Figure 3. Zinc Metal coordination mutations cause increased
levels of Mlh1-Pms1-4GFP foci. A. C-terminally tagged Pms1-GFP
was imaged in logarithmically growing asynchronous cultures of the
wild-type and the indicated pms1 mutant strains. The quantitative data
presented here, is the result of at least two independent experiments,
each performed using two independent strain isolates. The total
number of cells/nuclei (n) analyzed for each strain is indicated, and bars
indicate the error of the mean (SEM). B. C-terminally tagged Pms1-GFP
was imaged in logarithmically growing asynchronous cultures of wild-
type and the indicated mlh1-FERC mutant strains as described under A.
doi:10.1371/journal.pgen.1003869.g003
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the Mlh1-Pms1 endonuclease activity, which confirms and extends
previous studies of the human Mlh1-Pms2 E705K amino acid
substitution [25,26]. The pms1-H850R and the mlh1-E767stp
mutations resulted in proteins with partial defects in the in vitro
endonuclease assay, but caused complete MMR defects in vivo.
The partial endonuclease defect caused by these mutations may
reflect the fact that the in vivo metal ion in eukaryotic and bacterial
homologs is Zn2+, which has tetrahedral coordination geometry,
whereas the metal that promotes the in vitro assay is Mn2+, which
prefers an octahedral coordination geometry [25,48,60–63]. All of
the pms1 mutations that affect predicted metal binding ligands, as
well as mlh1-E767stp, caused complete MMR defects in vivo,
consistent with the observation that metal ligand defects in human
Mlh1-Pms2 inactivate MMR in vitro [26,63]. These mutations also
caused an accumulation of Mlh1-Pms1-4GFP foci indicating the
step at which these mutations disrupt MMR is after loading of
Mlh1-Pms1 by Msh2-Msh6, suggesting that loss of endonuclease
activity leads to a turnover defect of Mlh1-Pms1 during MMR.
A striking property of the dominant pms1 and mlh1 mutations is
that when present on a low copy plasmid they cause a much
greater defect in Exo1-independent MMR compared to MMR
when Exo1 is functional even though Mlh1-Pms1 appears to be
absolutely required for all MMR. This phenotype is similar to the
phenotype caused by the previously described separation-of-
function mutations in genes like MSH2, MSH3, MSH6, MLH1,
PMS1, POL30 and POL32 that result in strong defects in Exo1-
independent MMR but little if any defect in MMR when Exo1 is
functional [27]. A hypothesis that could explain these observations
is that Mlh1-Pms1 has two roles in MMR, one involving activation
of the Mlh1-Pms1 endonuclease and one where Mlh1-Pms1 plays
a role in the recruitment of downstream MMR factors. It was
previously shown that Exo1 interacts with Mlh1 and that this
interaction is required for Exo1 to function in MMR [50]. This
suggests the possibility that mispair recognition by Msh2-Msh6 or
Msh2-Msh3 recruits Mlh1-Pms1 which then targets Exo1 to DNA
where it could promote excision at pre-existing nicks in the DNA,
consistent with the observation that lagging strand MMR is more
Exo1 dependent than leading strand MMR [38,42]. Such a
reaction would be expected to be relatively insensitive to inhibition
by competition with an endonuclease inactive but structurally
normal form of Mlh1-Pms1 that would still bind Exo1 and target it
to the site of MMR. In contrast, MMR in the absence of Exo1
might be completely dependent on the Mlh1-Pms1 endonuclease
activity. This reaction would be expected to be competed for and
interfered with by the presence of endonuclease inactive but
structurally normal form of Mlh1-Pms1. A model that summarizes
these concepts is presented in Figure 4.
Materials and Methods
Strains and media
S. cerevisiae cells were grown in YEPD (1% yeast extract, 2%
Bacto peptone and 2% dextrose with or without 2% Bacto agar) or
SD (0.67% yeast nitrogen base and 2% dextrose with or without
2% Bacto agar) medium. SD medium was supplemented with the
appropriate dropout mix of amino acids (USA Biological). The S.
cerevisiae strains used in genetic experiments were derived from an
S288c parental strain and the strains used for protein purification
were derived from RDKY1293 or RDKY8053 (listed in Table
S3). All strains were constructed using standard gene disruption
and transformation procedures. E. coli strains were propagated in
LB media (0.5% yeast extract, 1% tryptone, 0.5% NaCl, 50 mg/ml
thymine with or without 2% Bacto agar) containing 100 mg/ml
ampicillin as required.
Plasmids and plasmid construction
All plasmids (listed in Table S4) were maintained in E. coli TOP
10F9. A pRS316 Ampr URA3 ARS-CEN PMS1 plasmid
pRDK1667 was constructed by recombination in vivo. Briefly,
PMS1 was amplified from S. cerevisiae S288c chromosomal DNA
using the primers 59ACGACGGCCAGTGAATTGTAATAC-
GACTCACTATAGGGCGAATTGGAGCTattgccaaacaggcaaa-
gac that contains 50 bp of homology to pRS316 upstream of the
multiple cloning site followed by 20 bp of homology to the PMS1
genes 707 bp upstream of the promoter starting at chromosome
XIV coordinate 472684 and 59TTAACCCTCACTAAAGG-
GAACAAAAGCTGGGTACCGGGCCCCCCCTCGAGgcata-
caagaaacaacgcga that contains 50 bp of homology to pRS316
encompassing the XhoI, DraII, ApaI and KpnI sites of the multiple
cloning site followed by 20 bp at the 39 end with homology to the
PMS1 genes 302 bp downstream of the stop codon from
chromosome XIV coordinate 476314. The PCR product was
Figure 4. Model of Exo1-dependent and Exo1-independent
resection of mispaired DNA. Mispaired DNA is recognized by the
Msh2-Msh6 heterodimer and subsequently recruits super-stoichiomet-
ric amounts of Mlh1-Pms1. In the absence of endonuclease function,
Mlh1-Pms1 has slow or no turnover and persistently remains on
damaged DNA. When the Mlh1-Pms1 endonuclease is functional, it can
introduce nicks into the DNA and either work in conjunction with Exo1
or function alone to resect past damaged DNA allowing for repair of
DNA damage.
doi:10.1371/journal.pgen.1003869.g004
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mixed with an equimolar amount of pRS316 that had been
linearized by digestion with SmaI and co-transformed into the
wild-type S. cerevisiae strain RDKY3590. The transformants were
selected on SC-uracil drop out plates, DNA was isolated from
individual transformants, rescued by transformation into E. coli
and sequenced. The plasmid selected for further use has a silent
C3055T mutation. A pRS426 Ampr URA3 2-micron PMS1
plasmid, pRDK1689, was constructed by subcloning the XhoI to
StuI (StuI cuts in the URA3 gene) PMS1 fragment from pRDK1667
into the XhoI to StuI backbone of pRS426. The pRS316 Ampr
URA3 ARS-CEN MLH1 plasmid pRDK1338 was from our
laboratory collection and contains a SacI to XhoI MLH1 fragment
inserted between the SacI and XhoI sites of pRS316. The MLH1
fragment starts at the native SacI site 2281 bp upstream of the
MLH1 ATG and ends at an XhoI site inserted by PCR 121 bp
downstream of the MLH1 stop codon. The 2-micron Mlh1 and
Pms1 over-expression plasmids pRDK573 TRP1 GAL10-MLH1
and pRDK1099 LEU2 GAL10-PMS1-FLAG have been described
previously [64]. Mutations were made in these plasmids using
standard site-directed mutagenesis methods or by subcloning from
a mutant plasmid and the resulting plasmids were verified by DNA
sequencing. The PMS1 mutant alleles E707K, H850R, C848S,
G683E and C817R were introduced at the chromosomal locus
using standard pop in/out techniques employing the integrative
plasmids listed in Table S4. These integration plasmids were
generated by subcloning the XhoI-StuI fragment containing the
pms1 mutant sequence from their respective pRS316-pms1 mutant
series plasmids into the XhoI-StuI sites of the pRS306 backbone
and were linearized with BlpI prior to transformation for
integration into the strains of interest. The MLH1 mutant alleles
E767stp and C769stp were introduced at the chromosomal locus
using standard gene disruption employing an HPH disruption
cassette generated by PCR such the upstream homology targeted
the C-terminus of MLH1 and contained the mutations needed
to introduce the E767stp and C769stp alleles. All of the
chromosomal pms1 and mlh1 mutations were verified by sequenc-
ing the entire PMS1 orMLH1 gene as relevant, which also ensured
that no additional mutations were introduced during strain
construction.
Isolation of random mutations in the PMS1 gene
Mutagenesis of the PMS1 gene by PCR was performed
essentially as previously described [65] with the following
modifications. The primers used for PCR were those described
above for amplification of PMS1. Ten PCR reactions were
performed using Klentaq DNA polymerase and a PMS1 gene
containing plasmid pRDK433 from our laboratory collection as a
template. The PCR reactions were pooled, aliquots of DNA were
mixed with an equimolar amount of pRS316 that had been
linearized by digestion with SmaI and co-transformed into the
wild-type S. cerevisiae strain RDKY3590. The transformants were
plated on SC-uracil drop out plates to select for transformants,
which were then replica plated onto SC-uracil-lysine drop out
plates to screen for colonies that had increased rates of reversion of
the lys2-A10 frameshift mutation. Candidate mutator mutants
were retrieved from the uracil drop out plates, restreaked on SC-
uracil drop out plates, patched in duplicate onto uracil drop out
plates and replica plated onto threonine-uracil drop out plates to
screen for patches that had increased rates of reversion of the
hom3-10 frameshift mutation. Plasmid DNA was isolated from
each mutator mutant, transformed into E. coli TOP10F9 and
sequenced. Individual mutations identified were then transferred
to a new pRS316 PMS1 plasmid pRDK1667 by either sub-cloning
using appropriate restriction endonuclease cleavage sites or by
site-directed mutagenesis and retested essentially as described for
the initial screen above.
Protein purification
S. cerevisiae Mlh1-Pms1 was purified from 2.2 L of culture of the
overproduction strain RDKY7608 (RDKY1293 containing the 2-
micron plasmids pRDK573 TRP1 GAL10-MLH1 and pRDK1099
LEU2 GAL10pr-PMS1-FLAG) (Table S3) according to a previously
published procedure [64], except with the following 6 modifica-
tions: (1) Cell growth and induction of Mlh1-Pms1 expression
utilized a published lactate to galactose shift protocol according to
previously published methods [66]; (2) 2 mM b-mercaptoethanol
was substituted for the 1 mM DTT in the buffers used to run the
Heparin and FLAG antibody columns whereas all other buffers
contained 1 mM DTT; (3) After washing the Heparin column
with Buffer A containing 200 mM NaCl, the proteins were eluted
using a single step of 1 M NaCl in Buffer A; (4) The pooled
Heparin column fractions were diluted with Buffer A to obtain a
final NaCl concentration of 500 mM prior to being subjected to 3
cycles of binding and elution from the FLAG antibody column; (5)
The SP Sepharose column fractions were diluted with Buffer A to
a final NaCl concentration of 200 mM prior to being loaded onto
a 1 ml HiTrap Q column (GE Healthcare) followed by elution
with a 100 mM to 1 M linear NaCl gradient run in Buffer A; and
(6) The HiTrap Q column fractions containing the Mlh1-Pms1
were concentrated and desalted using a Centraprep (Ultracel 30K)
spin column. The resulting Mlh1-Pms1 was contained in 0.5 ml of
Buffer A +100 mM NaCl, and was frozen in liquid nitrogen and
stored at 280 C. The Mlh1-Pms1-E707K, Mlh1-Pms1-C817R,
Mlh1-Pms1-C848S and Mlh1-Pms1-H850R proteins were puri-
fied using the overproduction strains RDKY7696, RDKY7756,
RDKY7759 and RDKY7793 (Table S3). The Mlh1-C769stp-
Pms1 and Mlh1-E767stp-Pms1 proteins were purified using the
overproduction strains RDKY8055 and RDKY8057 for which the
RDKY8053 host strain (Table S3) was a derivative of RDKY1293
containing a deletion of the MLH1 gene. Because mlh1-E767stp
allele does not compliment the MLH1 deletion in the host, after
the protein expression period, DNA was isolated from the culture,
20 independent MLH1 and PMS1 plasmids were rescued by
transformation into E. coli and sequenced to ensure that no
mutations had occurred in the expression plasmids. S. cerevisiae
PCNA and RFC-D1N were purified exactly as described in
published procedures [66–68]. All of the protein preparations used
in these studies were greater than 98% pure as analyzed by SDS-
PAGE.
Mlh1-Pms1 endonuclease assay
Mismatch-independent endonuclease assays were performed as
a modification of one used previously [26]. 40 mL reactions
containing 1 mM MnSO4, 20 mM Tris pH 7.5, 0.5 mM ATP
0.2 mg/mL bovine serum albumin (BSA), 2 mM DTT and
100 ng pRS425 were incubated at 30uC for 30 minutes. Reactions
were terminated by incubation at 55uC following introduction of
SDS, EDTA, glycerol and proteinase K at concentrations of 0.1%,
14 mM, 8% and 0.5 ug/ml respectively. Mlh1-Pms1, PCNA, or
RFC-D1N were diluted to the appropriate working concentrations
with a buffer comprised of 10% glycerol, 200 mM NaCl, 2 mM
DTT and 20 mM Tris pH 7.5. Following termination of the
reaction the samples were electrophoresed on a 0.8% agarose gel,
the gel was stained with ethidium bromide, extensively destained
and then the bands were quantified using a BioRad ChemiDoc
XP imaging system. Serial dilutions of XhoI linearized pRS425
ranging from 10–100 ng were used as a concentration standard for
quantification.
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Determination of mutation rates
Mutation rates were determined by fluctuation analysis. A single
colony was used to inoculate a culture that was then diluted and
used for transformation with a selectable plasmid carrying the
desired allele and transformed colonies were selected by growth for
3 days at 30uC on SC-uracil dropout plates. 7 independent
colonies were used to inoculate individual overnight cultures
containing 10 ml of SC-uracil dropout media. Following cell
growth, appropriate dilutions of the cultures were plated onto SC
–uracil, –uracil-lysine, -uracil-threonine, and -uracil-arginine+ca-
navanine dropout plates. The resulting colonies counted after
growth at 30uC for 3 days and the average mutation rate was
calculated for each strain as described previously [21,27]. Each
experiment was performed independently up to 4 times.
Molecular modeling
Site-directed mutagenesis was guided by a molecular model of
the C-terminal domains of Mlh1-Pms1. The C-terminus of S.
cerevisiae Mlh1 was modeled using Phyre, xfit, and CNS [69–71]
starting from the crystal structure of the human Mlh1 C-terminal
domain (PDB id 3rbn). The C-terminus of S. cerevisiae Pms1 was
similarly modeled using the crystal structures of N. gonorrhoeae [PDB
id 3ncv; [47]] and B. subtilis [PDB ids 3gab, 3kdg, 3kdk; [48]]
MutL homologs. Subsequently, the amino acid substitutions
studied were mapped onto the newly available structure of the
C-terminal domains of S. cerevisiae Mlh1-Pms1 [PDB id 4e4w;
[46]].
Live-cell imaging and image analysis
For microscopy studies, the C-terminus of each PMS1 protein
of interest was fluorescently tagged by targeting a 4GFP tag to the
chromosomal locus so that the native promoter was intact and
expression remained unaffected. Previous analysis of the tagged
PMS1 gene demonstrated that the 4GFP tag did not affect the
biological activity of Pms1 [38]. Exponentially growing cultures
were washed and resuspended in water, placed on minimal media
agar pads, covered with a coverslip, and imaged on a Deltavision
(Applied Precision) microscope with an Olympus 1006 1.35NA
objective. Fourteen 0.5 mm z sections were acquired and
deconvolved with softWoRx software. Further image processing,
including maximum intensity projections and intensity measure-
ments were performed using ImageJ.
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